KPNA3 was found overexpressed in the sorafenib-resistant PDX models and was further confirmed to induce EMT and sorafenib resistance of HCC cells through KPNA3-AKT-ERK-TWIST signalling. The gene discussed is KPNA3; the disease is hepatocellular carcinoma.